Canada's Series B+ venture capital market includes 36 active funds spanning multiple sectors and investment philosophies. These funds range from generalist capital providers to specialists focused on climate tech, life sciences, women-led founders, and agribusiness. Check sizes and deployment strategies vary significantly.
BDC's climate tech funds, for example, deploy $2M to $10M per deal in capital-intensive companies, while other funds focus on software and SaaS with different ticket sizes. Many funds operate with patient, multistage approaches rather than single-stage mandates. The investor base reflects both institutional capital and government-backed vehicles.
Several funds target underserved founder demographics or emerging sectors aligned with Canada's sustainability commitments. Life sciences investors like adMare focus on therapeutics commercialization from academic research. Meanwhile, traditional growth equity and buyout-focused funds round out the list.
This directory provides founders and operators a resource to identify which funds align with their sector, stage, and capital needs for Series B and beyond financing.
Canada's Global Life Sciences Venture, sourcing promising therapeutics research from academic and biotech partners to create new companies of scale and train the next generation of life sciences leade
Provides capital to help owner-operators take their companies to the next level, with focus on agribusiness, food & beverage, and industrial sectors.
A $600M BDC fund following a federal budget commitment. Flexible, multistage and patient capital approach for cleantech entrepreneurs. Portfolio of 50 companies. For every $1 BDC committed, $7.3 was r
A $400M BDC fund focused on capital-intensive, asset-heavy climate tech companies. Typical deals range $2M-$10M. Targets companies building technologies with direct material GHG emission reduction pot
A $300M BDC fund (Fund I + II) created to give ambitious Canadian entrepreneurs the capital and strategic advice to turn early-stage software companies into global technology leaders. Currently suppor
A $150M BDC fund investing in early-stage businesses developing software and asset-light technologies for a net-zero economy, aligned with UN SDGs. Equity investments up to $15M per company across app
The $300M direct investment component of BDC's Thrive Platform, addressing the equity gap faced by women-led companies. Partners with women entrepreneurs building Canadian technology companies.
A $200M fund — one of the world's largest dedicated to investing in women-led tech companies. Made 38 investments with 8 successful exits. Predecessor to the Thrive Platform.
Provides highly flexible growth financing solutions for small to mid-market companies across a wide variety of industry sectors. Fully funded by Beedie Development Group.
Evergreen investment fund supporting North American mid-market through direct investments and fund investments in buyout, growth equity and VC strategies.
Early-stage venture capital firm focused on Atlantic Canada, investing from seed through Series C.
Venture capital investor in media communication technologies, with 4 funds raised and 69 deals recorded.
Invest in high-growth tech startups across Prairies and Western Canada. Only local lead investor in SK.
Leading private ClimateTech VC platform investing across North America, Europe and Asia in companies enabling net-zero transition, reducing GHG emissions, and optimizing resources.
Venture capital fund investing in innovative Canadian companies in the food & beverage and health & wellness sectors.
Award-winning commercialization venture firm building companies with entrepreneurs to accelerate oncology innovation, partnered with the Ontario Institute for Cancer Research (OICR).
Toronto-based growth capital firm founded in 2008, one of Canada's largest investment firms, investing in enterprise software and internet companies with nearly $3B raised across 5 growth funds.
Leading seed-stage venture capital fund based in Toronto, investing across North America with 7 funds raised and 140 deals recorded.
Growth capital investment firm providing private funding and merchant banking services to a wide variety of businesses at different stages of development.
Focused exclusively on North American enterprise and financial technology companies, with 3 funds raised and 62 deals recorded.
Fund igniting precision medicine by supporting early-stage discoveries; innovation arm at the intersection of AI and biomarker analysis for metabolic diseases including cancer and diabetes.
Bridges a critical gap in early-stage funding, catalyzing later-stage funding for promising technology companies across enterprise software, health tech, clean tech and deep tech.
First dedicated Digital Industrial VC. Invests in Industrial AI and software at the intersection of data, automation, and large physical operations across North America, Europe, and Israel.
Corporate VC arm of National Bank of Canada. Direct equity investment in high growth potential technology companies.
Early-stage cleantech startups enhancing performance in natural gas value chain. Industry-backed model.
Wealth planning and investing firm (family office) with active venture and private equity investments across Canada.
Venture capital arm of OMERS pension fund with nearly $61B in net assets; 5 funds raised and 130 deals recorded across North America.
Early growth-stage technology venture capital investor with 7 funds raised and 41 deals recorded.
Global venture capital company focused on equity financing of innovative biotechnology companies with breakthrough technology platforms.
Backer of Canada's most daring innovators and idea generators; RBC's technology growth banking and venture arm.
Private venture capital and mutual fund management company with 1 fund and 51 deals recorded.
Founders Fund backed by successful entrepreneurs, with 7 funds raised and 91 deals recorded.
Emerging life science companies developing innovative medical treatments based on disruptive technologies.
Building global healthcare leaders from locally disruptive technologies. MedTech, Biotech, AI in Health.
International technology investment manager. Early Growth Fund, Digital Asset Fund, and North American Seed Fund.
Investment firm with a unique combination of water and investment expertise, focused on companies enabling efficient water use.